Saves lives by early diagnosis of lung, colorectal and prostate cancers.
ELAA Technology and Clionix inks the deal for exclusive distribution
Digital health is understood to mean “the field of knowledge and practice associated with the development and use of digital technologies to improve health. WHO is currently about to issue its Global Strategy on Digital Health. The purpose for a Global Strategy on Digital Health is to promote healthy lives and wellbeing for everyone, everywhere, at all ages. The broad scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.
ELAA Technology is a scale-up stage medical device startup developing products for early diagnosis of most common cancer types lung,colorectal and prostate. ELAA Technology’s proprietary Pure Digital Medical Navigation Platform enables the company to develop software as a medical device products and ELAA technology has just created its first for lung cancer early diagnostics product, PRECIMON™ which is a CE certified Class-II medical device and currently starting to be marketed in Europe.”
As technology continues to advance all facets of health care, software has become an important part of all products, integrated widely into digital platforms that serve both medical and non-medical purposes. Software, which on its own is a medical device – Software as a Medical Device – is one of three types of software related to medical devices. The other two types of software related to medical devices include software that is integral to a medical device (Software in a medical device) and software used in the manufacture or maintenance of a medical device.
The term “Software as a Medical Device” (SaMD) is defined as software intended to be used for one or more medical purposes that perform these purposes without being part of a hardware medical device